newsDrug prices in China cut by up to 61 percent for reimbursement scheme list2 December 2019 | By Victoria Rees (European Pharmaceutical Review)Top pharmaceutical companies have reduced their drug costs in China by an average of 61 percent, to be added to the reimbursement list in the country.
newsAsia-Pacific asthma market will hit $6 billion by 202311 June 2017 | By Niamh Marriott (European Pharmaceutical Review)The Asia-Pacific (APAC) asthma therapeutics market is expected to grow significantly from $4.1 billion in 2016 to around $6 billion by 2023...